Literature DB >> 10632825

HMG coenzyme A reductase inhibitors: good news and bad news.

M J Klag.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10632825      PMCID： PMC1496856          DOI： 10.1046/j.1525-1497.1999.14123.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  6 in total

1.  Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.

Authors:  S Warshafsky; D Packard; S J Marks; N Sachdeva; D M Terashita; G Kaufman; K Sang; A J Deluca; S J Peterson; W H Frishman
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

2.  Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease.

Authors:  S R Majumdar; J H Gurwitz; S B Soumerai
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

3.  Sick individuals and sick populations.

Authors:  G Rose
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

4.  Heart attacks: gone with the century?

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

5.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.

Authors:  H Iso; D R Jacobs; D Wentworth; J D Neaton; J D Cohen
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

6.  Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials.

Authors:  J He; P K Whelton; B Vu; M J Klag
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.